Molecular Partners AG
Stock Forecast, Prediction & Price Target
Molecular Partners AG Financial Estimates
Molecular Partners AG Revenue Estimates
Molecular Partners AG EBITDA Estimates
Molecular Partners AG Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| CHF9.33M N/A | CHF189.55M 1931.68% | CHF7.03M -96.28% | Avg: CHF18.66M Low: CHF15.13M High: CHF22.19M avg. 165.14% | Avg: CHF17.79M Low: CHF13.68M High: CHF21.89M avg. -4.66% | Avg: CHF75M Low: CHF57.69M High: CHF92.30M avg. 321.58% | Avg: CHF120M Low: CHF92.30M High: CHF147.69M avg. 60% |
Net Income
% change YoY
| CHF-63.78M N/A | CHF117.85M 284.76% | CHF-61.98M -152.59% | Avg: CHF-61.78M Low: CHF-80.28M High: CHF-41.40M avg. 0.32% | Avg: CHF-81.00M Low: CHF-88.48M High: CHF-55.87M avg. -31.10% | Avg: CHF-67.17M Low: CHF-87.33M High: CHF-47.02M avg. 17.06% | Avg: CHF-47.51M Low: CHF-61.77M High: CHF-33.26M avg. 29.26% |
EBITDA
% change YoY
| CHF-60.76M N/A | CHF120.12M 297.70% | CHF-59.51M -149.54% | Avg: CHF-12.56M Low: CHF-14.94M High: CHF-10.18M avg. 78.89% | Avg: CHF-11.97M Low: CHF-14.74M High: CHF-9.21M avg. 4.66% | Avg: CHF-50.49M Low: CHF-62.14M High: CHF-38.84M avg. -321.58% | Avg: CHF-80.79M Low: CHF-99.43M High: CHF-62.14M avg. -59.99% |
EPS
% change YoY
| -$2.06 N/A | $3.63 276.21% | -$1.89 -152.06% | Avg: -$1.86 Low: -$2.45 High: -$1.26 avg. 1.76% | Avg: -$2.2 Low: -$2.7 High: -$1.7 avg. -18.62% | Avg: -$2.05 Low: -$2.67 High: -$1.44 avg. 6.92% | Avg: -$1.45 Low: -$1.89 High: -$1.02 avg. 29.26% |
Operating Expenses
% change YoY
| CHF72.74M N/A | CHF72.94M 0.26% | CHF20.30M -72.16% | Avg: CHF24.07M Low: CHF19.52M High: CHF28.63M avg. 18.60% | Avg: CHF22.95M Low: CHF17.65M High: CHF28.25M avg. -4.66% | Avg: CHF96.77M Low: CHF74.44M High: CHF119.11M avg. 321.58% | Avg: CHF154.84M Low: CHF119.11M High: CHF190.58M avg. 60.00% |
FAQ
What is Molecular Partners AG stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 3.88% in 2025-2028.
We have gathered data from 2 analysts. Their low estimate is -80.28M, average is -61.78M and high is -41.40M.
What is Molecular Partners AG stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 135.51% in 2025-2028.
We have gathered data from 2 analysts. Their low revenue estimate is CHF15.13M, average is CHF18.66M and high is CHF22.19M.
What is Molecular Partners AG stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 4.83% in 2025-2028.
We have gathered data from 2 analysts. Their low earnings per share estimate is -$2.45, average is -$1.86 and high is CHF-1.26.